1. Home
  2. CRSP vs AUB Comparison

CRSP vs AUB Comparison

Compare CRSP & AUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$49.80

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$40.30

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
AUB
Founded
2013
1902
Country
Switzerland
United States
Employees
N/A
3064
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.1B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CRSP
AUB
Price
$49.80
$40.30
Analyst Decision
Buy
Strong Buy
Analyst Count
17
8
Target Price
$70.29
$41.88
AVG Volume (30 Days)
1.7M
875.1K
Earning Date
05-11-2026
04-21-2026
Dividend Yield
N/A
3.98%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$289,590,000.00
N/A
Revenue This Year
$807.72
$29.16
Revenue Next Year
$172.52
$4.59
P/E Ratio
N/A
$19.68
Revenue Growth
9169.85
N/A
52 Week Low
$40.76
$29.86
52 Week High
$78.48
$42.18

Technical Indicators

Market Signals
Indicator
CRSP
AUB
Relative Strength Index (RSI) 45.11 66.51
Support Level $46.15 $36.35
Resistance Level $59.61 $40.71
Average True Range (ATR) 2.91 0.85
MACD -0.35 0.28
Stochastic Oscillator 9.92 97.45

Price Performance

Historical Comparison
CRSP
AUB

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

Share on Social Networks: